SAN FRANCISCO, Jan. 26 /PRNewswire/ -- Scientists and senior level management executives will gather to exchange the latest drug discovery and development techniques at ALM’s Strategic Research Institute’s 11th Annual Inflammation & Immune Diseases Drug Discovery & Development Summit at the J.W. Marriott, San Francisco, CA, March 12-13, 2007.
The 2007 Summit’s distinguished Scientific Advisory Board members include: Alan Lewis, Ph.D., CEO Novocell, Inc. James G. Karras, Ph.D., Director, Inflammation, Antisense Drug Discovery ISISPHARMACEUTICALS Michael Amos, Ph.D., Technical Specialist, Advanced Technology Program NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY Martin Braddock, Ph.D., Director, Respiratory & Inflammation Research Area ASTRAZENECA UK Kate Blease, Ph.D., Senior Scientist CELGENE
Complete list of participating companies and institutions includes: Altana, Amgen, Array Biopharma, AstraZeneca, Berlex, Celgene, ChemoCentryx, Dynavax, ISIS, MD Biosciences, Merck, Millennium, National Institute of Standards and Technology, NIAMS, NIH, Novocell, novosom AG, Rigel, Roche, Sirna Therapeutics, UCLA, UCSD, UCSF, University of Maryland, ZymoGenetics.
The conference website is www.srinstitute.com/inflammation.
To receive the full agenda in PDF, register, or information on sponsorship/ exhibition opportunities, please contact Amy Yueh of Strategic Research Institute at ayueh@srinstitute.com or 212-967-0095, x258.
ABOUT STRATEGIC RESEARCH INSTITUTE
The Strategic Research Institute is part of ALM’s Conference and Trade Show Division, one of North America’s largest producers of educational and networking events for business leaders and the legal profession. The division offers more than 300 conferences and two leading industry tradeshows, as well as conferences in Europe and Asia. Attendance at the division’s events, which span a broad range of topics including law, finance, natural resources, life sciences, multi-cultural marketing, real estate and healthcare, will exceed 40,000 executive-level decision makers this year.
ABOUT ALM
Headquartered in New York City, ALM is a leading integrated media company, focused on the legal and business communities. ALM currently owns and publishes 37 national and regional magazines and newspapers, including The American Lawyer(R), Corporate Counsel(R), The National Law Journal(R) and Real Estate Forum(R). Other ALM businesses include Law.com(R), the Web’s leading legal news and information network, Law Journal Press books, newsletter publishing, court verdict and settlement reporting, production of professional educational seminars, market research and content distribution. ALM was formed by U.S. Equity Partners, L.P., a private equity fund sponsored by Wasserstein & Co., LP. More information on ALM’s businesses and services is available on the Web at www.alm.com.
Strategic Research Institute
CONTACT: Amy Yueh of Strategic Research Institute, +1-212-967-0095, x258,ayueh@srinstitute.com
